(Q52020790)

English

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

Natural T-helper immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: identification of 3 human leukocyte antigen class II-restricted epitopes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

human papilloma virus

1 reference

object named as

human papillomavirus

29 September 2024

based on heuristic

inferred from title

Kees L M C Franken

9

object named as

K L Franken

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

author name string

S H van der Burg

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

M E Ressing

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

K M Kwappenberg

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

A de Jong

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

K Straathof

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

J de Jong

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

A Geluk

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

K E van Meijgaarden

8

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

T H Ottenhoff

10

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

G J Fleuren

11

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

G Kenter

12

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

C J Melief

13

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

R Offringa

14

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

language of work or name

0 references

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

91

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

612-618

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Strategies for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

CD4 T cells and their role in antitumor immune responses

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Automated reading of Propidium Iodide lymphocytotoxicity tests for HLA-DR, MB, MT typing

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Natural history of cervicovaginal papillomavirus infection in young women

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

T-cell deficiency in patients with squamous cell cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection

1 reference

https://api.crossref.org/works/10.1002%2F1097-0215%28200002%299999%3A9999%3C%3A%3AAID-IJC1119%3E3.0.CO%3B2-C

21 January 2018

Identifiers

10.1002/1097-0215(200002)9999:9999<::AID-IJC1119>3.0.CO;2-C

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

release_burj6op6tvdfdajzf6qoezisku

1 reference

https://api.fatcat.wiki/v0/release/burj6op6tvdfdajzf6qoezisku

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/11267969

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52020790&oldid=2254324601"